ReviewsREVIEW

Childhood undernutrition, the gut microbiota, and microbiota-directed therapeutics

See allHide authors and affiliations

Science  24 Jun 2016:
Vol. 352, Issue 6293, pp. 1533
DOI: 10.1126/science.aad9359

eLetters is an online forum for ongoing peer review. Submission of eLetters are open to all. eLetters are not edited, proofread, or indexed.  Please read our Terms of Service before submitting your own eLetter.

Compose eLetter

Plain text

  • Plain text
    No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Author Information
First or given name, e.g. 'Peter'.
Your last, or family, name, e.g. 'MacMoody'.
Your email address, e.g. higgs-boson@gmail.com
Your role and/or occupation, e.g. 'Orthopedic Surgeon'.
Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.
Statement of Competing Interests
CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Image CAPTCHA
Enter the characters shown in the image.

Vertical Tabs

  • RE: Undernutrition and the gut microbiota
    • Silvio Pitlik, Physician, Weizmann Institute of Science
    • Other Contributors:
      • Nina Pitlik, Pharmacologist, Tel Aviv-Jaffa Academic College

    Natural consolidation of a robust microbiota is a longstanding and complex process resulting in an highly diversified and resilient microbial community. In sharp contrast, significant perturbations of these optimally functioning ecological niches may result from acute and aggressive factors such as the administration of a very short course of antibiotics. Repair of a perturbed microbiota is almost always an unreachable goal, as demonstrated by frequent failure of probiotics in a myriad of clinical situations. We believe that a deep understanding of the intimate mechanisms of the perturbation microbiota in childhood undernutrition may help in the prevention of this horrible and ubiquitous problem rather than in its cure once it has been developed.

    Competing Interests: None declared.

Navigate This Article